Testing a new contrast agent for ovarian mass ultrasound
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial is testing an investigational contrast agent (FRD001) to see if it improves ultrasound images of suspicious ovarian masses. The goal is to help doctors better tell if a mass is cancerous or not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have at least one ovarian cyst or solid mass that hasn't been treated yet.
- Your overall health is good enough that you can likely live at least 3 months.
- Your blood counts, liver and kidney function, and heart function meet certain lab values.
- You are willing to use effective birth control during the study (if you could become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug (SHR-A1811) versus standard chemotherapy for women with platinum-resistant ovarian cancer. The study looks at a specific protein (HER2) to see if the new treatment can help slow or stop the cancer.
This study tests a new imaging agent that may help doctors see tumors more clearly using a special scan (SPECT). It is for people with solid tumors to check if the agent is safe and how well it finds cancer cells.
This study tests whether a special ultrasound using a contrast agent can better tell if an ovarian lesion is benign or malignant. The goal is to help doctors make more accurate decisions without surgery.
This trial tests a new imaging method that uses a special tracer (like a dye) to light up ovarian cancer cells on a PET/CT scan. It aims to help doctors see the cancer more clearly and to check whether treatment is working, which could lead to better care for people with advanced or recurrent ovarian cancer.
This study tests a computer program that helps doctors read ultrasound images of the ovaries. It aims to make diagnosing ovarian masses more accurate and easier, which may lead to better care for women with these findings.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
Hear when a new Ovary Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.